<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0">
<channel>
<title><![CDATA[Journal of Orthopaedic & Sports Physical Therapy - Lene Christensen, BSciPhysio, M Manip Ther]]></title>
<link>http://www.jospt.org/lenechristensen</link>
<description></description>
<language></language>
<copyright></copyright>
<lastBuildDate>Wed, 30 Apr 2008 09:05:25 EST</lastBuildDate>
<docs></docs>
<generator></generator>
<managingEditor></managingEditor>
<webMaster></webMaster>
<ttl>0</ttl>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom"  rel="self" href="" type="application/rss+xml" /><item>
<title>Efficacy of a C1-C2 Self-sustained Natural Apophyseal Glide (SNAG) in the Management of Cervicogenic Headache</title>
<link>http://www.jospt.org/issues/articleID.1208/article_detail.asp</link>
<description><![CDATA[<a href="http://www.jospt.org/rss/author.tobyhall/author.asp">Toby Hall</a>, <a href="http://www.jospt.org/rss/author.kimrobinson/author.asp">Kim Robinson</a>, <a href="http://www.jospt.org/rss/author.hotakchan/author.asp">Ho Tak Chan</a>, <a href="http://www.jospt.org/rss/author.lenechristensen/author.asp">Lene Christensen</a>, <a href="http://www.jospt.org/rss/author.brittaodenthal/author.asp">Britta Odenthal</a>, <a href="http://www.jospt.org/rss/author.cheriewells/author.asp">Cherie Wells</a><br /><p><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><font color="#000099"><strong>STUDY DESIGN:</strong></font> </span></span><span style="font-family: Arial">Randomized, double-blind, placebo controlled trial. </span></font><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><font color="#000099"><strong>OBJECTIVES:</strong></font> </span></span><span style="font-family: Arial">To determine the effect of a C1-C2 self-sustained natural apophyseal glide (SNAG) on cervicogenic headache. </span></font><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><font color="#000099"><strong>BACKGROUND:</strong></font> </span></span><span style="font-family: Arial">Cervicogenic headache is a common condition causing significant disability. Recent studies have shown a high incidence of C1-C2 dysfunction, evaluated by the flexion-rotation test (FRT), in subjects with cervicogenic headache. To manage this dysfunction, Mulligan has described a C1-C2 self-SNAG, though no studies have investigated the efficacy of this intervention approach. </span></font><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><strong><font color="#000099">METHODS:</font></strong> </span></span><span style="font-family: Arial">A sample of 32 subjects (mean &plusmn; SD age, 36 &plusmn; 3 years) with cervicogenic headache and FRT limitation were randomized into a C1-C2 self-SNAG or placebo group. After an initial instruction and practice visit in the clinic, interven&shy;tions consisted of exercises applied independently by the subject twice daily at home on a continual basis. FRT range was measured twice, before and immediately after the instruction and practice visit. Headache symptoms were determined by a headache index over time, assessed by question&shy;naire preintervention, at 4 weeks postintervention, and at 12 months postintervention. </span></font><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><strong><font color="#000099">RESULTS:</font></strong> </span></span><span style="font-family: Arial">No differences were found in baseline measures between groups. Immedi&shy;ately after the initial instruction and practice visit performed with the supervision of the therapist, FRT range increased by 15&deg; (SD, 9) for the C1-C2 self-SNAG group (<em>P</em>&lt;.001), which was significantly more than 5&deg; (SD, 5) for the placebo intervention (<em>P</em>&lt;.001). There was also a significant interaction for the variable headache index between group and time (<em>P</em>&lt;.001), indicating that group difference was dependent on time. There was no difference in headache index scores at baseline between groups. Headache index scores were substantially less in the C1-C2 self-SNAG group (mean &plusmn; SD points at 4 weeks, 31 &plusmn; 9; mean &plusmn; SD points at 12 months, 24 &plusmn; 9) compared to the placebo group (mean &plusmn; SD points at 4 weeks, 51 &plusmn; 15; mean &plusmn; SD points at 12 months, 44 &plusmn; 13) at 4 weeks (<em>P</em>&lt;.001) and 12 months (<em>P</em>&lt;.001), with an overall (&plusmn;SD) reduction of 54% (&plusmn;17%) for the individu&shy;als in the C1-C2 self-SNAG group. </span></font><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><strong><font color="#000099">CONCLUSIONS:</font></strong> </span></span><span style="font-family: Arial">These results provide evidence for the efficacy of the C1-C2 self-SNAG technique in the management of individuals with cervicogenic headache.&nbsp;</span></font><span style="font-family: Arial"><font size="2">&nbsp;</font></span></p><p><span style="font-family: Arial"></span><font size="2"><em><span style="font-family: Arial">J Orthop Sports Phys Ther. 2007;37(3):100-107. </span></em><span style="font-family: Arial">doi:10.2519/jospt.2007.2379</span></font><span class="A8"><span style="color: windowtext; font-family: Arial"><font size="2">&nbsp;</font></span></span>&nbsp; </p><p style="margin: 0pt 0pt 2pt" class="Pa5"><font size="2"><span class="A8"><span style="color: windowtext; font-family: Arial"><strong><font color="#000099">KEY WORDS:</font></strong> </span></span><span style="font-family: Arial">atlantoaxial joint, cervical spine, flexion-rotation test, joint mobilization, Mulligan</span></font></p>]]></description>
<guid>http://www.jospt.org/issues/articleID.1208/article_detail.asp</guid>
</item>
</channel></rss>
